Back to Search
Start Over
Akston Biosciences Touts Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate
- Source :
- M2 Pharma. July 9, 2021
- Publication Year :
- 2021
-
Abstract
- M2 PHARMA-July 9, 2021-Akston Biosciences Touts Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate (C)2021 M2 COMMUNICATIONS - US-based biologic therapeutics developer Akston Biosciences Corp has released positive results [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.667965595